Medulloblastoma: this old dewormer could stop relapses of brain tumors in children

In almost one in three children with medulloblastoma, the brain tumor returns and unfortunately leaves little hope. But a derivative of an old dewormer approved in the United States seems to slow down these relapses in preclinical models.